<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Patients with chronic liver disease have associated comorbidities that require treatment, including cardiovascular disease, arrhythmias, cerebrovascular accidents and pain. These medications may affect the liver disease. Due to the complexity of medical problems in patients with chronic liver disease, treating clinicians benefit from targeted guidance for their care.</p></abstract>

Patients with chronic liver disease have associated comorbidities that require treatment, including cardiovascular disease, arrhythmias, cerebrovascular accidents and pain. These medications may affect the liver disease. Due to the complexity of medical problems in patients with chronic liver disease, treating clinicians benefit from targeted guidance for their care.

Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians

Romanian Journal of Internal Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Patients with chronic liver disease have associated comorbidities that require treatment, including cardiovascular disease, arrhythmias, cerebrovascular...

Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians

Publicado en línea: 17 dic 2020

Páginas: 181 - 187

Recibido: 04 jun 2020

DOI: https://doi.org/10.2478/rjim-2020-0018

Palabras clave
liver enzymes, aminotransferases, benefits, risk factors, recommendations

© 2020 Sean Sileno et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians

Publicado en línea: 17 dic 2020

Páginas: 181 - 187

Recibido: 04 jun 2020

DOI: https://doi.org/10.2478/rjim-2020-0018

Palabras claveliver enzymes, aminotransferases, benefits, risk factors, recommendations

© 2020 Sean Sileno et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Palabras clave
liver enzymes, aminotransferases, benefits, risk factors, recommendations